nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenoxylate—Loperamide—POMC—polycystic ovary syndrome	0.0224	0.275	CrCbGaD
Diphenoxylate—Clotrimazole—CYP17A1—polycystic ovary syndrome	0.0163	0.2	CrCbGaD
Diphenoxylate—Clotrimazole—CYP11A1—polycystic ovary syndrome	0.016	0.197	CrCbGaD
Diphenoxylate—Clotrimazole—CYP19A1—polycystic ovary syndrome	0.00828	0.102	CrCbGaD
Diphenoxylate—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.00828	0.102	CrCbGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00571	0.00622	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00559	0.00608	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00556	0.00605	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00556	0.00605	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00553	0.00602	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00549	0.00597	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00541	0.00589	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00532	0.00579	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00526	0.00572	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00523	0.00569	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00518	0.00563	CbGpPWpGaD
Diphenoxylate—Cinnarizine—CYP1A1—polycystic ovary syndrome	0.00515	0.0634	CrCbGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00514	0.0056	CbGpPWpGaD
Diphenoxylate—OPRM1—IL4-mediated signaling events—IRS1—polycystic ovary syndrome	0.00504	0.00549	CbGpPWpGaD
Diphenoxylate—Methadone—CYP19A1—polycystic ovary syndrome	0.00485	0.0598	CrCbGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00478	0.00521	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0047	0.00512	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00466	0.00507	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00466	0.00507	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.0046	0.00501	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0046	0.00501	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00448	0.00488	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00438	0.00477	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00436	0.00475	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00426	0.00464	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00423	0.00461	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00421	0.00458	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00412	0.00448	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.0041	0.00446	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00407	0.00443	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00405	0.00441	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00401	0.00436	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00394	0.00429	CbGpPWpGaD
Diphenoxylate—OPRM1—Opioid Signalling—POMC—polycystic ovary syndrome	0.00392	0.00427	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00391	0.00426	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0039	0.00424	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00387	0.00421	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00385	0.00419	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00384	0.00418	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00381	0.00415	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00377	0.0041	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00377	0.0041	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00375	0.00408	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00358	0.0039	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00355	0.00387	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00355	0.00387	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.0035	0.00381	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00348	0.00379	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00347	0.00378	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00341	0.00371	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00336	0.00365	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00335	0.00365	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00333	0.00362	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00323	0.00351	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00323	0.00351	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00323	0.00351	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00316	0.00344	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00314	0.00342	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00312	0.0034	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00302	0.00329	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.003	0.00327	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00297	0.00323	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00293	0.00319	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.0029	0.00316	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00287	0.00313	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00287	0.00312	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00286	0.00311	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00285	0.00311	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00285	0.0031	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00279	0.00304	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00279	0.00304	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00278	0.00303	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00268	0.00291	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00265	0.00289	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00264	0.00288	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00263	0.00287	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00263	0.00287	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00261	0.00285	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.0026	0.00283	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00259	0.00282	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00259	0.00282	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00257	0.0028	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00249	0.00271	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00248	0.0027	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00246	0.00268	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00239	0.0026	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00239	0.0026	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00239	0.0026	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00238	0.00259	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00236	0.00257	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00233	0.00253	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00229	0.00249	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00228	0.00249	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00226	0.00246	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00226	0.00246	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00224	0.00244	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00221	0.00241	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00219	0.00238	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00217	0.00236	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00216	0.00235	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00213	0.00232	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00212	0.00231	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00212	0.0023	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00211	0.0023	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00208	0.00226	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00207	0.00225	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00206	0.00224	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00203	0.00221	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00202	0.0022	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00201	0.00219	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00198	0.00216	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00196	0.00213	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00194	0.00211	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00193	0.0021	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00193	0.0021	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00192	0.00209	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00191	0.00208	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00191	0.00208	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00184	0.002	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00179	0.00195	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00178	0.00194	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00176	0.00192	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00175	0.00191	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00173	0.00188	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0017	0.00185	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00169	0.00184	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00168	0.00183	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00168	0.00183	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00167	0.00182	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00164	0.00179	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00164	0.00178	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00162	0.00177	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0016	0.00174	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00157	0.00171	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.00157	0.0017	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00154	0.00168	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00153	0.00167	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00153	0.00167	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00152	0.00166	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.0015	0.00164	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.0015	0.00163	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00149	0.00163	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00149	0.00162	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00143	0.00155	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00141	0.00154	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00141	0.00154	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.0014	0.00152	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00137	0.00149	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00136	0.00148	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00136	0.00148	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00133	0.00145	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00132	0.00144	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00131	0.00143	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00128	0.0014	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00128	0.00139	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00125	0.00136	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.00124	0.00135	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00124	0.00135	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00123	0.00134	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00122	0.00132	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00121	0.00132	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00119	0.00129	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00115	0.00125	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00115	0.00125	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00114	0.00124	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00114	0.00124	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00112	0.00122	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00111	0.00121	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00109	0.00118	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00107	0.00116	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00106	0.00115	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00104	0.00113	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00103	0.00113	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00101	0.0011	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00101	0.00109	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000988	0.00107	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000974	0.00106	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000973	0.00106	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000946	0.00103	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000931	0.00101	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000922	0.001	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000917	0.000998	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000911	0.000991	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.0009	0.000979	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000885	0.000963	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00088	0.000957	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000871	0.000948	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000862	0.000939	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000852	0.000927	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00085	0.000925	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000843	0.000918	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000832	0.000906	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000804	0.000875	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000802	0.000872	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000802	0.000872	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000791	0.00086	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000784	0.000853	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000772	0.000841	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000772	0.00084	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000765	0.000832	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000746	0.000812	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000742	0.000808	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000732	0.000797	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000722	0.000786	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000706	0.000768	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000701	0.000763	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000699	0.000761	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00069	0.000751	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000674	0.000734	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000664	0.000722	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000656	0.000714	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000646	0.000703	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000639	0.000696	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000615	0.00067	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000594	0.000647	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000594	0.000647	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000586	0.000638	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000575	0.000626	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000572	0.000623	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000567	0.000617	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000553	0.000602	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00055	0.000599	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000523	0.000569	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00052	0.000566	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000518	0.000564	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.0005	0.000544	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000493	0.000536	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000492	0.000535	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000482	0.000525	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000456	0.000496	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000434	0.000473	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00043	0.000468	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000426	0.000464	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000414	0.000451	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000412	0.000448	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000399	0.000434	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000398	0.000433	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000378	0.000412	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000365	0.000397	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000357	0.000389	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000319	0.000347	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000307	0.000334	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000305	0.000332	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000305	0.000332	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000295	0.000321	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000295	0.000321	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00028	0.000305	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.00026	0.000283	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000226	0.000246	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000193	0.00021	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	0.00018	0.000196	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000133	0.000145	CbGpPWpGaD
